DexCom | 10-Q: Quarterly report
Apr 25 17:21 ET
DexCom | 8-K: Dexcom Reports First Quarter 2024 Financial Results
Apr 25 16:11 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 23 16:06 ET
DexCom | DEF 14A: Definitive information statements
Apr 22 22:16 ET
DexCom | ARS: Annual Report to Security Holders
Apr 22 16:42 ET
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Dolan Matthew Vincent
Apr 16 16:22 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 15 16:15 ET
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer SAYER KEVIN R
Apr 10 16:08 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 8 16:08 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 1 18:23 ET
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Brown Michael Jon
Mar 29 19:33 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 28 16:41 ET
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Stern Sadie
Mar 26 16:50 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 25 16:15 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 25 16:14 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 25 16:13 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 22 16:31 ET
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Dolan Matthew Vincent
Mar 19 16:57 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 15 16:47 ET
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 15 16:42 ET
No Data
No Data